QUEST Research Institute

Summary

QUEST Research Institute is a medical facility located in Farmington, Michigan. This center is recognized for care of Parkinson's Disease, Alzheimer's Disease, Dementia, Cognitive Impairment, Migraine and other specialties. QUEST Research Institute is involved with conducting 111 clinical trials across 114 conditions. There are 3 research doctors associated with this hospital, such as Aaron Ellenbogen, DO, MPH, Peter LeWitt, and Mohammed Ibrahim, MD.

Top PIs

Clinical Trials running at QUEST Research Institute

Parkinson's Disease

Alzheimer's Disease

Cognitive Impairment

Dementia

Memory Loss

Neurodegenerative Diseases

Healthy Subjects

Parkinson's disease

Epilepsy

Multiple Sclerosis

CREXONT ER

for Parkinson's Disease

The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).

Recruiting

3 awards

Phase 4

2 criteria

Bemdaneprocel

for Parkinson's Disease

Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).

Recruiting

1 award

Phase 3

3 criteria

CVN424

for Parkinson's Disease

This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily oral doses of either 75 milligrams (mg) CVN424 or 150 mg CVN424, or a matching placebo for 12 weeks. Participants who successfully complete this study and retain eligibility/suitability will be invited to participate in a future open-label extension (OLE) study.

Recruiting

1 award

Phase 3

17 criteria